Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

HMGB1 loves company.

Bianchi ME.

J Leukoc Biol. 2009 Sep;86(3):573-6. doi: 10.1189/jlb.1008585. Epub 2009 May 4. Review.

PMID:
19414536
2.

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

Hreggvidsdottir HS, Ostberg T, Wähämaa H, Schierbeck H, Aveberger AC, Klevenvall L, Palmblad K, Ottosson L, Andersson U, Harris HE.

J Leukoc Biol. 2009 Sep;86(3):655-62. doi: 10.1189/jlb.0908548. Epub 2009 Jun 29.

PMID:
19564572
3.
4.
5.

High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists.

Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ 3rd.

J Immunol. 2006 Dec 15;177(12):8701-7.

6.

High mobility group box 1 protein interacts with multiple Toll-like receptors.

Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E.

Am J Physiol Cell Physiol. 2006 Mar;290(3):C917-24. Epub 2005 Nov 2.

PMID:
16267105
7.

Induction of inflammatory and immune responses by HMGB1-nucleosome complexes: implications for the pathogenesis of SLE.

Urbonaviciute V, Fürnrohr BG, Meister S, Munoz L, Heyder P, De Marchis F, Bianchi ME, Kirschning C, Wagner H, Manfredi AA, Kalden JR, Schett G, Rovere-Querini P, Herrmann M, Voll RE.

J Exp Med. 2008 Dec 22;205(13):3007-18. doi: 10.1084/jem.20081165. Epub 2008 Dec 8.

8.

High-mobility group box 1 (HMGB1) protein: friend and foe.

Ulloa L, Messmer D.

Cytokine Growth Factor Rev. 2006 Jun;17(3):189-201. Epub 2006 Mar 2. Review.

PMID:
16513409
9.

The effect of HMGB1, a damage-associated molecular pattern molecule, on polymorphonuclear neutrophil migration depends on its concentration.

Berthelot F, Fattoum L, Casulli S, Gozlan J, Maréchal V, Elbim C.

J Innate Immun. 2012;4(1):41-58. doi: 10.1159/000328798. Epub 2011 Aug 19.

10.

Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1).

van Beijnum JR, Buurman WA, Griffioen AW.

Angiogenesis. 2008;11(1):91-9. doi: 10.1007/s10456-008-9093-5. Epub 2008 Feb 9. Review.

PMID:
18264787
11.

Mini-review: The nuclear protein HMGB1 as a proinflammatory mediator.

Erlandsson Harris H, Andersson U.

Eur J Immunol. 2004 Jun;34(6):1503-12. Review.

12.

High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity.

Bianchi ME, Manfredi AA.

Immunol Rev. 2007 Dec;220:35-46. Review.

PMID:
17979838
13.

Synergism of toll-like receptor 2 (TLR2), TLR4, and TLR6 ligation on the production of tumor necrosis factor (TNF)-alpha in a spontaneous arthritis animal model of interleukin (IL)-1 receptor antagonist-deficient mice.

Jung YO, Cho ML, Lee SY, Oh HJ, Park JS, Park MK, Park MJ, Ju JH, Kim SI, Park SH, Kim HY, Min JK.

Immunol Lett. 2009 Apr 27;123(2):138-43. doi: 10.1016/j.imlet.2009.03.004. Epub 2009 Mar 21.

PMID:
19428561
14.

HMGB1 preconditioning: therapeutic application for a danger signal?

Klune JR, Billiar TR, Tsung A.

J Leukoc Biol. 2008 Mar;83(3):558-63. Epub 2007 Oct 15. Review.

PMID:
17938274
15.

Introduction: HMGB1 in inflammation and innate immunity.

Andersson U, Rauvala H.

J Intern Med. 2011 Oct;270(4):296-300. doi: 10.1111/j.1365-2796.2011.02430.x. No abstract available.

16.

Targeting HMGB1/TLR4 signaling as a novel approach to treatment of cerebral ischemia.

Yang QW, Xiang J, Zhou Y, Zhong Q, Li JC.

Front Biosci (Schol Ed). 2010 Jun 1;2:1081-91. Review.

PMID:
20515842
17.

HMGB1 develops enhanced proinflammatory activity by binding to cytokines.

Sha Y, Zmijewski J, Xu Z, Abraham E.

J Immunol. 2008 Feb 15;180(4):2531-7.

18.

TLR2/TLR4-independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus.

Rönnefarth VM, Erbacher AI, Lamkemeyer T, Madlung J, Nordheim A, Rammensee HG, Decker P.

J Immunol. 2006 Dec 1;177(11):7740-9.

19.

Interleukin-1 type 1 receptor/Toll-like receptor signalling in epilepsy: the importance of IL-1beta and high-mobility group box 1.

Maroso M, Balosso S, Ravizza T, Liu J, Bianchi ME, Vezzani A.

J Intern Med. 2011 Oct;270(4):319-26. doi: 10.1111/j.1365-2796.2011.02431.x.

20.

HMGB1: a signal of necrosis.

Raucci A, Palumbo R, Bianchi ME.

Autoimmunity. 2007 Jun;40(4):285-9. Review.

PMID:
17516211

Supplemental Content

Support Center